TJP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.18345391451203E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.54789999998684E-07 |
Normal-vs-Stage2 |
3.24890000014122E-07 |
Normal-vs-Stage3 |
1.74726899615507E-12 |
Normal-vs-Stage4 |
1.81288317691042E-12 |
Stage1-vs-Stage2 |
6.602200E-02 |
Stage1-vs-Stage3 |
8.76099999991276E-07 |
Stage1-vs-Stage4 |
2.2142999999919E-05 |
Stage2-vs-Stage3 |
2.634800E-01 |
Stage2-vs-Stage4 |
1.223960E-01 |
Stage3-vs-Stage4 |
4.794000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.04236627610044E-12 |
Normal-vs-AfricanAmerican |
4.57519999996769E-06 |
Normal-vs-Asian |
1.360240E-01 |
Caucasian-vs-AfricanAmerican |
7.942600E-01 |
Caucasian-vs-Asian |
3.342000E-01 |
AfricanAmerican-vs-Asian |
4.886000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.05093711511017E-12 |
Normal-vs-Female |
2.14869999570766E-09 |
Male-vs-Female |
2.382000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.442200E-03 |
Normal-vs-Age(41-60Yrs) |
4.1752999946354E-08 |
Normal-vs-Age(61-80Yrs) |
1.63147273468667E-12 |
Normal-vs-Age(81-100Yrs) |
1.58730000032747E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.668200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.310200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.241700E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.421770E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.718200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.849770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.530600E-01 |
Normal-vs-Grade 2 |
1.65914999999961E-05 |
Normal-vs-Grade 3 |
2.27373675443232E-13 |
Normal-vs-Grade 4 |
4.44089209850063E-16 |
Grade 1-vs-Grade 2 |
1.513790E-02 |
Grade 1-vs-Grade 3 |
5.944000E-03 |
Grade 1-vs-Grade 4 |
1.462790E-03 |
Grade 2-vs-Grade 3 |
3.72559999961553E-07 |
Grade 2-vs-Grade 4 |
9.41509981089439E-10 |
Grade 3-vs-Grade 4 |
1.090250E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.57127999999007E-05 |
Normal-vs-ccB subtype |
2.08622008557313E-12 |
ccA subtype-vs-ccB subtype |
3.7552999999968E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.84305953516196E-12 |
Normal-vs-N1 |
2.10000000000488E-06 |
N0-vs-N1 |
1.340820E-01 |
|
|